Investment Summary

Ranbaxy Laboratories Invests In Zenotech Laboratories

On October 3, 2007, Ranbaxy Laboratories invested in life science company Zenotech Laboratories

Investment Highlights
  • This is Ranbaxy Laboratories’ 2nd transaction in the Life Science sector.
  • This is Ranbaxy Laboratories’ 1st transaction in India.

Investment Summary
Date 2007-10-03
Target Zenotech Laboratories
Sector Life Science
Investor(s) Ranbaxy Laboratories
Deal Type Stake Purchase

Target

Zenotech Laboratories

Hyderabad, India
Zenotech Laboratories Limited, a pharmaceutical specialty generic injectables company, manufactures bio-technology products.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Ranbaxy Laboratories

New Delhi, India
Category Company
Founded 1961
Sector Life Science
Employees15,300
DESCRIPTION

Ranbaxy Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed and emerging 4 markets, many of which incorporate proprietary Novel Drug Delivery Systems and technologies developed at its own labs.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Stake Purchase) 1 of 1
Country (India) 1 of 1
Year (2007) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-03-29 Terapia SA

Cluj-Napoca, Romania

Terapia, then second-largest pharmaceuticals manufacturer in Romania, was a household name with an 80-year heritage.

Buy $324M
Mergr

Product

Company

Legal